MedTrace Logo

Ramadan Fasting in Patients With Corticotrope Deficiency Treated Either by Hydrocortisone or by Prednisolone

NCT03585829 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2019-04-29

No results posted yet for this study

Summary

Selected patients will be randomised to either hydrocortisone or prednisolone. Each treatment period is of 14 days. Abnormal clinical symptoms, blood glucose and quality of life will be monitored.

Conditions

  • Corticotropin Deficiency
  • Fasting

Interventions

DRUG

Hydrocortisone

at a substitutive dosage

DRUG

Prednisolone

at a substitutive dosage

Sponsors & Collaborators

  • University Tunis El Manar

    lead OTHER

Principal Investigators

  • Hedia Slimane, MD · University Tunis El Manar

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-17
Primary Completion
2018-06-16
Completion
2018-07-25

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03585829 on ClinicalTrials.gov